Hepatic Contrast–Enhancing Properties of Manganese–Mesoporphyrin and Manganese–TPPS: A Comparative Magnetic Resonance Imaging Study in Rats4: A Comparative Magnetic Resonance Imaging Study in Rats

Abstract

Manganese (III) mesoporphyrin (Mn–mesoporphyrin), a synthetic and stable complex, was investigated for its hepatic magnetic resonance imaging (MRI) properties and compared with manganese tetrakis–(4 sulfonatophenyl) porphyrin (Mn–TPPS4).

Liver abscesses (n = 10) and tumors (n = 14) were induced in rats. These rats then underwent MRI at 2.0 T. Animals received one of the two contrast agents, and measurement of lesion enhancement was performed.

At an intravenous dose of 0.035 mmol/kg, Mn–mesoporphyrin caused significant enhancement of normal liver parenchyma and increased the lesion–to–liver contrast in both the models of heptic liver abscess and metastatic liver disease. Mn–TTPS4 at an intravenous dose of 0.04 mmol/kg typically enhanced both lesion and normal liver parenchyma and therefore did not improve the lesion–to–liver contrast.

The hepatotrophic properties of Mnmesoporphyrin indicate its potential as an intravenous contrast agent for liver imaging